Pulmonális artériás hipertónia: vizsgálatok itt: Görögország
9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 15.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
- Where
- Athens, Chaïdári, Kallithea, Thessaloniki
- Életkor
- 18 év and over
- People
- 85 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2024-513613-12-00 - 2. fázisNot yet taking people in GörögországClinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH)
- Where
- Chaïdári, Thessaloniki
- Életkor
- 18 év to 75 év
- People
- 135 worldwide
- Run by
- NS Pharma, Inc.
See details and how to joinNCT07441200 · EU 2025-525114-38-00 - 3. fázisTaking peopleEfficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Where
- Athens, Heraklion, Kallithea, Pátrai, Thessaloniki
- Életkor
- 18 év and over
- People
- 344 worldwide
- Run by
- Insmed Incorporated
See details and how to joinNCT07179380 · EU 2025-521558-40-00 - 3. fázisFut, nem toborozOpen-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
- Where
- Athens, Kallithea, Thessaloniki
- Életkor
- 18 év to 75 év
- People
- 330 worldwide
- Run by
- Gossamer Bio USA, Inc.
See details and how to joinNCT06274801 · EU 2023-506334-75-00 - 3. fázisNot yet taking people in GörögországA Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
- Where
- Athens, Chaïdári, Kallithea, Thessaloniki
- Életkor
- 18 év to 75 év
- People
- 344 worldwide
- Run by
- Insmed Incorporated
See details and how to joinNCT07481981 · EU 2026-525265-48-00 - 3. fázisFut, nem toborozA Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
- Where
- Alexandroupoli, Kallithea, Thessaloniki
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- United Therapeutics
See details and how to joinNCT03683186 · EU 2023-509305-68-00 - 3. fázisTaking peopleAn Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
- Where
- Chaïdári, Thessaloniki
- Életkor
- 18 év to 75 év
- People
- 486 worldwide
- Run by
- Inhibikase Therapeutics
See details and how to joinNCT07365332 · EU 2024-520218-23-00 - 2. fázisNot yet taking people in GörögországCS1 Added to Standard of Care Therapy for Pulmonary Arterial Hypertension
- Where
- Kallithea, Larissa, Thessaloniki
- Életkor
- 18 év to 80 év
- People
- 126
- Run by
- Cereno Scientific AB
See details and how to joinNCT07761572 · EU 2026-526523-22-00 - 1/2. fázisTaking peopleA Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
- Where
- Athens, Chaïdári, Thessaloniki
- Életkor
- 18 év to 100 év
- People
- 232 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06649110